CMTM4 and cancer: Since we found significant reduced tumor growth with CMTM4 KD/KO cancer cells in vivo (Fig. 2A–C) but not in vitro (Appendix Fig. S4C), we determined whether the immune response, especially the adaptive immunity, is required for the retarded tumor growth.